Julie Eastland

President, Chief Executive Officer and Director

CEO Board Member Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Zentalis Pharmaceuticals, Inc. (ZNTL)	President and Chief Executive Officer	$700,000	—	$99,772	$56,975	$441,000	$2,984	$1,300,731
2024	Zentalis Pharmaceuticals, Inc. (ZNTL)	President and Chief Executive Officer	$94,231	$250,000	—	$7,791,824	$52,471	$383	$8,188,909

Executive changes

Appointed Class I director at Zentalis Pharmaceuticals, Inc. (ZNTL)
2024-11-13
Appointed Chief Executive Officer at Zentalis Pharmaceuticals, Inc. (ZNTL)
2024-11-13
Appointed Class I Director at Lantheus Holdings, Inc. (LNTH)
2024-09-03
Resigned director of the Company and member of the Committees of the Board at CalciMedica, Inc. (CALC)
2023-02-09

Earnings-call appearances

Jefferies Global Healthcare Conference in New York
Zentalis Pharmaceuticals, Inc. (ZNTL)

2026-06-03
H.C. Wainwright 4th Annual BioConnect Conference at Nasdaq
Zentalis Pharmaceuticals, Inc. (ZNTL)

2026-05-19